Yoo JK - Search Results

1

Design, synthesis, and structure-activity relationship of carbamate-tethered aryl propanoic acids as novel PPARalpha/gamma dual agonists.

Kim NJ, Lee KO, Koo BW, Li F, Yoo JK, Park HJ, Min KH, Lim JI, Kim MK, Kim JK, Suh YG. Kim NJ, et al. Among authors: yoo jk. Bioorg Med Chem Lett. 2007 Jul 1;17(13):3595-8. doi: 10.1016/j.bmcl.2007.04.057. Epub 2007 Apr 25. Bioorg Med Chem Lett. 2007. PMID: 17507225

2

Rational design of an indolebutanoic acid derivative as a novel aldose reductase inhibitor based on docking and 3D QSAR studies of phenethylamine derivatives.

Sun WS, Park YS, Yoo J, Park KD, Kim SH, Kim JH, Park HJ. Sun WS, et al. J Med Chem. 2003 Dec 18;46(26):5619-27. doi: 10.1021/jm0205346. J Med Chem. 2003. PMID: 14667216

3

Synthesis and biological evaluation of 3-(4-substituted-phenyl)-N-hydroxy-2-propenamides, a new class of histone deacetylase inhibitors.

Kim DK, Lee JY, Kim JS, Ryu JH, Choi JY, Lee JW, Im GJ, Kim TK, Seo JW, Park HJ, Yoo J, Park JH, Kim TY, Bang YJ. Kim DK, et al. J Med Chem. 2003 Dec 18;46(26):5745-51. doi: 10.1021/jm030377q. J Med Chem. 2003. PMID: 14667227

4

Synthesis and biological evaluation of 4(5)-(6-alkylpyridin-2-yl)imidazoles as transforming growth factor-beta type 1 receptor kinase inhibitors.

Kim DK, Jang Y, Lee HS, Park HJ, Yoo J. Kim DK, et al. J Med Chem. 2007 Jun 28;50(13):3143-7. doi: 10.1021/jm070129k. Epub 2007 Jun 7. J Med Chem. 2007. PMID: 17552507

5

3D-QSAR studies on sildenafil analogues, selective phosphodiesterase 5 inhibitors.

Yoo J, Thai KM, Kim DK, Lee JY, Park HJ. Yoo J, et al. Bioorg Med Chem Lett. 2007 Aug 1;17(15):4271-4. doi: 10.1016/j.bmcl.2007.05.064. Epub 2007 May 24. Bioorg Med Chem Lett. 2007. PMID: 17553682

6

Concise syntheses of (+)-macrosphelides A and B: studies on the macro-ring closure strategy.

Paek SM, Yun H, Kim NJ, Jung JW, Chang DJ, Lee S, Yoo J, Park HJ, Suh YG. Paek SM, et al. J Org Chem. 2009 Jan 16;74(2):554-61. doi: 10.1021/jo8016692. J Org Chem. 2009. PMID: 19086801

7

Computer-aided identification of ligands for GPCR anti-obesity targets.

Min KH, Yoo J, Park HJ. Min KH, et al. Curr Top Med Chem. 2009;9(6):539-53. doi: 10.2174/156802609788897871. Curr Top Med Chem. 2009. PMID: 19689364 Review.

8

Synthesis and biological evaluation of 4(5)-(6-methylpyridin-2-yl)imidazoles and -pyrazoles as transforming growth factor-beta type 1 receptor kinase inhibitors.

Kim DK, Lee YI, Lee YW, Dewang PM, Sheen YY, Kim YW, Park HJ, Yoo J, Lee HS, Kim YK. Kim DK, et al. Bioorg Med Chem. 2010 Jun 15;18(12):4459-67. doi: 10.1016/j.bmc.2010.04.071. Epub 2010 Apr 28. Bioorg Med Chem. 2010. PMID: 20472445

9

Discovery of new ERRγ agonists regulating dopaminergic neuronal phenotype in SH-SY5Y cells.

Kim T, Kim HI, Oh H, Jeon Y, Shin H, Kim HS, Lim J, Lim C, Yoo J, Suh YG, Son WS, Choi HJ, Kim SH. Kim T, et al. Bioorg Chem. 2022 May;122:105716. doi: 10.1016/j.bioorg.2022.105716. Epub 2022 Mar 11. Bioorg Chem. 2022. PMID: 35303621

10

Biarylpyrazolyl oxadiazole as potent, selective, orally bioavailable cannabinoid-1 receptor antagonists for the treatment of obesity.

Lee SH, Seo HJ, Lee SH, Jung ME, Park JH, Park HJ, Yoo J, Yun H, Na J, Kang SY, Song KS, Kim MA, Chang CH, Kim J, Lee J. Lee SH, et al. J Med Chem. 2008 Nov 27;51(22):7216-33. doi: 10.1021/jm800843r. J Med Chem. 2008. PMID: 18954042

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

215 results

Search Page

Filters